Sign in
Explore the registryTrack Capivasertib's trials

CAPItello-292

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

CapivasertibOngoingActive not recruitingPhase 3Open NCT04862663 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…